Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.100 | 0.867 | 15 | 2007 | 2020 | ||||
Malignant neoplasm of breast
|
3417 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.100 | 0.867 | 15 | 2007 | 2020 | ||||
Down Syndrome
|
80 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.100 | 0.833 | 12 | 2003 | 2014 | ||||
Complete Trisomy 21 Syndrome
|
77 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.100 | 0.818 | 11 | 2003 | 2014 | ||||
Neural Tube Defects
|
122 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.090 | 0.667 | 9 | 1997 | 2018 | ||||
Coronary Artery Disease
|
1577 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.080 | 1.000 | 8 | 1999 | 2017 | ||||
Coronary heart disease
|
1178 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.080 | 1.000 | 8 | 2001 | 2019 | ||||
Male infertility
|
146 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.060 | 0.833 | 6 | 2006 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.060 | 0.667 | 6 | 2008 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.060 | 0.667 | 6 | 2008 | 2018 | ||||
Adenoma of large intestine
|
213 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 0.800 | 5 | 1998 | 2013 | ||||
Colorectal Carcinoma
|
1962 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 0.600 | 5 | 1999 | 2013 | ||||
Malignant neoplasm of prostate
|
1082 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||
Myocardial Infarction
|
680 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 0.800 | 5 | 2001 | 2012 | ||||
Prostate carcinoma
|
1168 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2002 | 2012 | ||||
Alzheimer's Disease
|
1843 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 0.750 | 4 | 2003 | 2008 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2012 | 2019 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2003 | 2015 | ||||
Adult Lymphoma
|
66 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 0.333 | 3 | 2004 | 2017 | ||||
Childhood Lymphoma
|
66 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 0.333 | 3 | 2004 | 2017 | ||||
Coronary Arteriosclerosis
|
440 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 1.000 | 3 | 2001 | 2005 | ||||
Hyperhomocysteinemia
|
45 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 1.000 | 3 | 2002 | 2017 | ||||
Lymphoma
|
91 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 0.333 | 3 | 2004 | 2017 | ||||
Multiple Myeloma
|
865 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 0.667 | 3 | 2003 | 2008 |